NEW FINDINGS: What is the central question of this study? Do obese women with relatively high whole-body iron stores exhibit elevated in vivo rates of fatty acid (FA) release from adipose tissue compared with a well-matched cohort of obese women with relatively low iron stores? What is the main finding and its importance? Obese women with high plasma [ferritin] (a marker of whole-body iron stores) had greater FA mobilization, lipolytic activation in adipose tissue and insulin resistance (IR) compared with obese women with lower plasma [ferritin]. Given that elevated FA mobilization is intimately linked with the development of IR, these findings suggest that elevated iron stores might contribute to IR in obesity by increasing systemic FA availability. ABSTRACT: High rates of fatty acid (FA) mobilization from adipose tissue are associated with insulin resistance (IR) in obesity. In vitro evidence suggests that iron stimulates lipolysis in adipocytes, but whether iron is related to in vivo FA mobilization is unknown. We hypothesized that plasma ferritin concentration ([ferritin]), a marker of body iron stores, would be positively associated with FA mobilization. We measured [ferritin], the rate of appearance of FA in the systemic circulation (FA Ra; stable isotope dilution), key adipose tissue lipolytic proteins and IR (hyperinsulinaemic-euglycaemic clamp) in 20 obese, premenopausal women. [Ferritin] was correlated with FA Ra (r = 0.65; P = 0.002) and IR (r = 0.57; P = 0.008); these relationships remained significant after controlling for body mass index and plasma [C-reactive protein] (a marker of systemic inflammation) in multiple regression analyses. We then stratified subjects into tertiles based on [ferritin] to compare subjects with 'High-ferritin' versus 'Low-ferritin'. Plasma [hepcidin] was more than fivefold greater (P < 0.05) in the High-ferritin versus Low-ferritin group, but there was no difference in plasma [C-reactive protein] between groups, indicating that the large difference in plasma [ferritin] reflects a difference in iron stores, not systemic inflammation. We found that FA Ra, adipose protein abundance of hormone-sensitive lipase and adipose triglyceride lipase, and IR were significantly greater in subjects with High-ferritin versus Low-ferritin (all P < 0.05). These data provide the first evidence linking iron and in vivo FA mobilization and suggest that elevated iron stores might contribute to IR in obesity by increasing systemic FA availability.
NEW FINDINGS: What is the central question of this study? Do obesewomen with relatively high whole-body iron stores exhibit elevated in vivo rates of fatty acid (FA) release from adipose tissue compared with a well-matched cohort of obesewomen with relatively low iron stores? What is the main finding and its importance? Obesewomen with high plasma [ferritin] (a marker of whole-body iron stores) had greater FA mobilization, lipolytic activation in adipose tissue and insulin resistance (IR) compared with obesewomen with lower plasma [ferritin]. Given that elevated FA mobilization is intimately linked with the development of IR, these findings suggest that elevated iron stores might contribute to IR in obesity by increasing systemic FA availability. ABSTRACT: High rates of fatty acid (FA) mobilization from adipose tissue are associated with insulin resistance (IR) in obesity. In vitro evidence suggests that iron stimulates lipolysis in adipocytes, but whether iron is related to in vivo FA mobilization is unknown. We hypothesized that plasma ferritin concentration ([ferritin]), a marker of body iron stores, would be positively associated with FA mobilization. We measured [ferritin], the rate of appearance of FA in the systemic circulation (FA Ra; stable isotope dilution), key adipose tissue lipolytic proteins and IR (hyperinsulinaemic-euglycaemic clamp) in 20 obese, premenopausal women. [Ferritin] was correlated with FA Ra (r = 0.65; P = 0.002) and IR (r = 0.57; P = 0.008); these relationships remained significant after controlling for body mass index and plasma [C-reactive protein] (a marker of systemic inflammation) in multiple regression analyses. We then stratified subjects into tertiles based on [ferritin] to compare subjects with 'High-ferritin' versus 'Low-ferritin'. Plasma [hepcidin] was more than fivefold greater (P < 0.05) in the High-ferritin versus Low-ferritin group, but there was no difference in plasma [C-reactive protein] between groups, indicating that the large difference in plasma [ferritin] reflects a difference in iron stores, not systemic inflammation. We found that FA Ra, adipose protein abundance of hormone-sensitive lipase and adipose triglyceride lipase, and IR were significantly greater in subjects with High-ferritin versus Low-ferritin (all P < 0.05). These data provide the first evidence linking iron and in vivo FA mobilization and suggest that elevated iron stores might contribute to IR in obesity by increasing systemic FA availability.
Authors: Nick Wlazlo; Marleen M J van Greevenbroek; Isabel Ferreira; Eugene H J M Jansen; Edith J M Feskens; Carla J H van der Kallen; Casper G Schalkwijk; Bert Bravenboer; Coen D A Stehouwer Journal: Acta Diabetol Date: 2014-10-01 Impact factor: 4.280
Authors: Hong Wang; Urmila Sreenivasan; Da-Wei Gong; Kelly A O'Connell; Erinne R Dabkowski; Peter A Hecker; Nicoleta Ionica; Manige Konig; Anup Mahurkar; Yezhou Sun; William C Stanley; Carole Sztalryd Journal: J Lipid Res Date: 2013-01-23 Impact factor: 5.922
Authors: José María Moreno-Navarrete; Marta G Novelle; Victoria Catalán; Francisco Ortega; Maria Moreno; Javier Gomez-Ambrosi; Gemma Xifra; Marta Serrano; Ester Guerra; Wifredo Ricart; Gema Frühbeck; Carlos Diéguez; José Manuel Fernández-Real Journal: Diabetes Care Date: 2014-02-04 Impact factor: 19.112
Authors: Nick Wlazlo; Marleen M J van Greevenbroek; Isabel Ferreira; Eugene H J M Jansen; Edith J M Feskens; Carla J H van der Kallen; Casper G Schalkwijk; Bert Bravenboer; Coen D A Stehouwer Journal: Diabetes Care Date: 2012-09-06 Impact factor: 19.112
Authors: Jeb S Orr; Arion Kennedy; Emily K Anderson-Baucum; Corey D Webb; Steve C Fordahl; Keith M Erikson; Yaofang Zhang; Anders Etzerodt; Søren K Moestrup; Alyssa H Hasty Journal: Diabetes Date: 2013-10-15 Impact factor: 9.461